"In Vivo" Comparison in Human Carotid Atherosclerosis: Plaque

Status Completed

Clinical Trial Summary

Atherosclerosis may initiate early in life and takes years to progress. This contrasts to the abrupt coronary or cerebrovascular events occurring following the transition from a stable to an unstable atherosclerotic plaque. The causes of this discontinuity of the disease are complex and probably multiple. There is increasing evidence that, besides inflammation, neovascularisation of atherosclerotic plaques and intra-plaque hemorrhages play an important role in plaque instability ending-up frequently in acute thrombotic occlusion or distal embolisation of athero-thrombotic material associated with heart attack or stroke. Contrast-enhanced Ultrasound, is a bed-side non-invasive technique, which allows to enhance microvascular structures and to visualize the adventitia and intraplaque vascularization. Dynamic contrast-enhanced plaque MRI (DCE-MRI) which has also been evaluated for in vivo detection and quantification of plaque neovascularity. Together with the presence of a large lipid-rich core, thin fibrous cap, positive remodeling and active inflammatory infiltrate, plaque neovascularisation is considered a valid marker of high-risk (or vulnerable) plaque as demonstrated in histopathological studies using microvessel density.

Aim of the study is to assess and validate the value of contrast enhanced ultrasound (CEUS), a bed-side technique, in detecting plaque neovascularisation and compare it with the quantitative assessment by DCE-MRI in carotis atherosclerosis.

A group of 30 patients with asymptomatic carotid atherosclerosis (> 50% stenosis on Doppler ultrasound) will undergo Carotid Duplex ultrasounds and CEUS. High-resolution plaque MRI and DCE-MRI will be performed in the same patients and will be analyzed by two separate operators blinded to the results of the CEUS in order to detect the efficacy of CEUS when compared with in vivo DCE-MRI, as the standard of reference.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02321410
Study type	Interventional
Source	Ospedale San Giovanni Bellinzona
Contact
Status	Completed
Phase	N/A
Start date	February 2014
Completion date	April 2016

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02124928` - Morphological and Serological Criteria of Plaque Vulnerability: Risk Assessment for Symptomatic and Asymptomatic Carotid Artery Stenosis	N/A
Active, not recruiting	`NCT01597453` - NOR-SYS: The Norwegian Stroke in the Young Study	N/A
Completed	`NCT00744523` - Proximal Protection With The Mo.Ma Device During Carotid Stenting	N/A
Completed	`NCT00231231` - Carotid Artery Stenting With Emboli Protection Surveillance-Post-Marketing Study (CASES-PMS)	Phase 3
Completed	`NCT00597974` - Neurological Outcome With Carotid Artery Stenting	N/A
Completed	`NCT00587717` - The Acute Effect of Statins on Inflammatory Markers of Athersclerotic Tissue	N/A
Completed	`NCT02536378` - POST-APPROVAL STUDY of TRANSCAROTID ARTERY REVASCULARIZATION in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE
Completed	`NCT02126982` - Salts of Clopidogrel: Investigation to ENsure Clinical Equivalence
Active, not recruiting	`NCT01445613` - Carotid Artery Stenting Outcomes in the Standard Risk Population for Carotid Endarterectomy	N/A
Terminated	`NCT01414387` - Effects of Cerebral Protection With Filters vs. Flow Reversal on Cerebral Embolization After Carotid Artery Stenting	N/A
Completed	`NCT00406055` - CHOICE: Carotid Stenting For High Surgical-Risk Patients	Phase 4
Completed	`NCT00403078` - SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy
Terminated	`NCT01968226` - TRACER RGD-K5 Carotid Plaque Imaging Study	Phase 2
Completed	`NCT01685567` - Safety and Efficacy Study for Reverse Flow Used During Carotid Artery Stenting Procedure	Phase 3
Completed	`NCT00402740` - Protected Carotid Artery Stenting in Subjects at High Risk for Carotid Endarterectomy (CEA) (PROTECT)	N/A
Completed	`NCT00287508` - Emboshield® and Xact® Post Approval Carotid Stent Trial (The EXACT Study)	Phase 4
Completed	`NCT00178672` - A Single Center of Carotid Stenting With Distal Protection for the Treatment of Obstructive Carotid Artery Disease	Phase 4
Recruiting	`NCT02850588` - SVS VQI TransCarotid Revascularization Surveillance Project
Completed	`NCT02759653` - Norwegian Carotid Plaque Study
Withdrawn	`NCT01042912` - Frequency Analysis of Carotid Artery Disease	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

"In Vivo" Comparison in Human Carotid Atherosclerosis: Plaque Neovascularization — PLAVASC

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms